These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23783998)

  • 1. [Opinion. The German Ophthalmological Society,the Retina Society and the Professional Association of German Ophthalmologists. Treatment of diabetic maculopathy].
    Ophthalmologe; 2013 Jun; 110(6):568-88. PubMed ID: 23783998
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists: treatment of diabetic maculopathy (April 2013)].
    ; Ziemssen F; Helbig H; Lemmen KD; Spital G; Bertram B; Hillenkamp J; Bartz-Schmidt KU; Bornfeld N; Bresgen M; Eter N; Friedrichs W; Heimann H; Hoerauf H; Holz FG; Kampik A; Kirchhof B; Pauleikhoff D; Roider J; ; ;
    Klin Monbl Augenheilkd; 2013 Jun; 230(6):614-28. PubMed ID: 23794430
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendation of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany: treatment of diabetic maculopathy].
    Klin Monbl Augenheilkd; 2011 May; 228(5):446-59. PubMed ID: 21534178
    [No Abstract]   [Full Text] [Related]  

  • 4. [Statement of the German Ophthalmological Society, the German Retina Society and the Professional Association of German Ophthalmologists: The anti-VEGF therapy in neovascular age-related macular degeneration: Therapeutic Strategies (November 2014)].
    Gesellschaft DO
    Klin Monbl Augenheilkd; 2015 Feb; 232(2):202-10. PubMed ID: 25700258
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-VEGF: one drug for different conditions?].
    Cohen SY; Massin P; Souied E
    J Fr Ophtalmol; 2013 Jan; 36(1):2-4. PubMed ID: 23290491
    [No Abstract]   [Full Text] [Related]  

  • 6. Availability of anti-VEGF agents for the management of advanced diabetic retinopathy in the NHS.
    Malik A; Zambarakji H
    Br J Ophthalmol; 2013 Feb; 97(2):236-7. PubMed ID: 23197397
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study.
    Cheema RA; Al-Mubarak MM; Amin YM; Cheema MA
    J Cataract Refract Surg; 2009 Jan; 35(1):18-25. PubMed ID: 19101420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months.
    Arevalo JF; Lasave AF; Wu L; Diaz-Llopis M; Gallego-Pinazo R; Alezzandrini AA; Berrocal MH;
    Retina; 2013 Feb; 33(2):403-13. PubMed ID: 23222389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists therapy for choroidal neovascularization in myopia ].
    Pauleikhoff D; Bertram B; Claessens D; ; ;
    Klin Monbl Augenheilkd; 2014 May; 231(5):548-53. PubMed ID: 24799174
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial.
    Preti RC; Ramirez LM; Monteiro ML; Carra MK; Pelayes DE; Takahashi WY
    Br J Ophthalmol; 2013 Jul; 97(7):885-9. PubMed ID: 23686001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etiopatogenezis clinic end treatment of diabetic rethinopathy].
    Antelava N; Antelava N
    Georgian Med News; 2011 Sep; (198):7-12. PubMed ID: 22156669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019.
    ; ;
    Ophthalmologe; 2021 Jan; 118(Suppl 1):40-67. PubMed ID: 33033871
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
    Naser H; Koss MJ; Singh P; Koch F
    Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of anti-VEGF (anti-vascular endothelial growth factor) in Retinopathy of Prematurity (ROP)].
    González Viejo I; Ferrer Novella C; Pueyo Royo V
    Arch Soc Esp Oftalmol; 2011 Jul; 86(7):207-8. PubMed ID: 21798405
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta-analysis of randomized controlled trials.
    Zhang ZH; Liu HY; Hernandez-Da Mota SE; Romano MR; Falavarjani KG; Ahmadieh H; Xu X; Liu K
    Am J Ophthalmol; 2013 Jul; 156(1):106-115.e2. PubMed ID: 23791371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series.
    Abdelhakim MA; Macky TA; Mansour KA; Mortada HA
    Ophthalmic Res; 2011; 45(1):23-30. PubMed ID: 20714187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OCT and cataract.
    Falavarjani KG; Modarres M; Nikeghbali A
    Ophthalmology; 2010 Apr; 117(4):849; author reply 849-50. PubMed ID: 20346827
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy.
    Ernst BJ; García-Aguirre G; Oliver SC; Olson JL; Mandava N; Quiroz-Mercado H
    Acta Ophthalmol; 2012 Nov; 90(7):e573-4. PubMed ID: 22405048
    [No Abstract]   [Full Text] [Related]  

  • 19. Sight-threatening diabetic eye disease: an update and review of the literature.
    Symes RJ; Liew G; Tufail A
    Br J Gen Pract; 2014 Oct; 64(627):e678-80. PubMed ID: 25267057
    [No Abstract]   [Full Text] [Related]  

  • 20. The relation between bevacizumab injection and the formation of subretinal fibrosis in diabetic patients with panretinal photocoagulation.
    Batman C; Ozdamar Y
    Ophthalmic Surg Lasers Imaging; 2010; 41(2):190-5. PubMed ID: 20307036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.